Beyond Histology: Translating Tumor Genotypes into Clinically Effective Targeted Therapies

被引:49
作者
Meador, Catherine B. [1 ]
Micheel, Christine M. [2 ,5 ]
Levy, Mia A. [2 ,3 ,5 ]
Lovly, Christine M. [1 ,2 ,5 ]
Horn, Leora [2 ,5 ]
Warner, Jeremy L. [2 ,3 ,5 ]
Johnson, Douglas B. [2 ,5 ]
Zhao, Zhongming [2 ,3 ,5 ]
Anderson, Ingrid A. [5 ]
Sosman, Jeffrey A. [2 ,5 ]
Vnencak-Jones, Cindy L. [4 ,5 ]
Dahlman, Kimberly B. [1 ,5 ]
Pao, William [1 ,2 ,4 ,5 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
关键词
CELL LUNG-CANCER; RECEPTOR TYROSINE KINASE; OPEN-LABEL; BRAF MUTATIONS; PHASE-II; ADVANCED MELANOMA; DOSE-ESCALATION; ACQUIRED-RESISTANCE; THERAPEUTIC TARGET; 1ST-LINE TREATMENT;
D O I
10.1158/1078-0432.CCR-13-1591
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Increased understanding of intertumoral heterogeneity at the genomic level has led to significant advancements in the treatment of solid tumors. Functional genomic alterations conferring sensitivity to targeted therapies can take many forms, and appropriate methods and tools are needed to detect these alterations. This review provides an update on genetic variability among solid tumors of similar histologic classification, using non-small cell lung cancer and melanoma as examples. We also discuss relevant technological platforms for discovery and diagnosis of clinically actionable variants and highlight the implications of specific genomic alterations for response to targeted therapy. (C) 2014 AACR.
引用
收藏
页码:2264 / 2275
页数:12
相关论文
共 106 条
[1]   Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers [J].
Adjei, Alex A. ;
Cohen, Roger B. ;
Franklin, Wilbur ;
Morris, Clive ;
Wilson, David ;
Molina, Julian R. ;
Hanson, Lorelei J. ;
Gore, Lia ;
Chow, Laura ;
Leong, Stephen ;
Maloney, Lara ;
Gordon, Gilad ;
Simmons, Heidi ;
Marlow, Allison ;
Litwiler, Kevin ;
Brown, Suzy ;
Poch, Gregory ;
Kane, Katie ;
Haney, Jerry ;
Eckhardt, S. Gail .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) :2139-2146
[2]   Signatures of mutational processes in human cancer [J].
Alexandrov, Ludmil B. ;
Nik-Zainal, Serena ;
Wedge, David C. ;
Aparicio, Samuel A. J. R. ;
Behjati, Sam ;
Biankin, Andrew V. ;
Bignell, Graham R. ;
Bolli, Niccolo ;
Borg, Ake ;
Borresen-Dale, Anne-Lise ;
Boyault, Sandrine ;
Burkhardt, Birgit ;
Butler, Adam P. ;
Caldas, Carlos ;
Davies, Helen R. ;
Desmedt, Christine ;
Eils, Roland ;
Eyfjord, Jorunn Erla ;
Foekens, John A. ;
Greaves, Mel ;
Hosoda, Fumie ;
Hutter, Barbara ;
Ilicic, Tomislav ;
Imbeaud, Sandrine ;
Imielinsk, Marcin ;
Jaeger, Natalie ;
Jones, David T. W. ;
Jones, David ;
Knappskog, Stian ;
Kool, Marcel ;
Lakhani, Sunil R. ;
Lopez-Otin, Carlos ;
Martin, Sancha ;
Munshi, Nikhil C. ;
Nakamura, Hiromi ;
Northcott, Paul A. ;
Pajic, Marina ;
Papaemmanuil, Elli ;
Paradiso, Angelo ;
Pearson, John V. ;
Puente, Xose S. ;
Raine, Keiran ;
Ramakrishna, Manasa ;
Richardson, Andrea L. ;
Richter, Julia ;
Rosenstiel, Philip ;
Schlesner, Matthias ;
Schumacher, Ton N. ;
Span, Paul N. ;
Teague, Jon W. .
NATURE, 2013, 500 (7463) :415-+
[3]  
[Anonymous], EUR CANC C
[4]   Detection of KRAS and BRAF Mutations in Colorectal Carcinoma Roles for High-Sensitivity Locked Nucleic Acid-PCR Sequencing and Broad-Spectrum Mass Spectrometry Genotyping [J].
Arcila, Maria ;
Lau, Christopher ;
Nafa, Khedoudja ;
Ladanyi, Marc .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2011, 13 (01) :64-73
[5]   Early clinical results of intraoperative radiation therapy (IORT) during breast conservation using an electronic brachytherapy (EBX) technique. [J].
Arterbery, V. Elayne ;
Johnson, Pamela .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
[6]   MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study [J].
Ascierto, Paolo A. ;
Schadendorf, Dirk ;
Berking, Carola ;
Agarwala, Sanjiv S. ;
van Herpen, Carla M. L. ;
Queirolo, Paola ;
Blank, Christian U. ;
Hauschild, Axel ;
Beck, J. Thaddeus ;
St-Pierre, Annie ;
Niazi, Faiz ;
Wandel, Simon ;
Peters, Malte ;
Zubel, Angela ;
Dummer, Reinhard .
LANCET ONCOLOGY, 2013, 14 (03) :249-256
[7]   Major Clinical Response to a BRAF Inhibitor in a Patient With a BRAF L597R-Mutated Melanoma [J].
Bahadoran, Philippe ;
Allegra, Maryline ;
Le Duff, Florence ;
Long-Mira, Elodie ;
Hofman, Paul ;
Giacchero, Damien ;
Passeron, Thierry ;
Lacour, Jean-Philippe ;
Ballotti, Robert .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (19) :E324-E326
[8]   KIT Gene Mutations and Copy Number in Melanoma Subtypes [J].
Beadling, Carol ;
Jacobson-Dunlop, Erick ;
Hodi, F. Stephen ;
Le, Claudia ;
Warrick, Andrea ;
Patterson, Janice ;
Town, Ajia ;
Harlow, Amy ;
Cruz, Frank, III ;
Azar, Sharl ;
Rubin, Brian P. ;
Muller, Susan ;
West, Rob ;
Heinrich, Michael C. ;
Corless, Christopher L. .
CLINICAL CANCER RESEARCH, 2008, 14 (21) :6821-6828
[9]   Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors [J].
Bendell, Johanna C. ;
Rodon, Jordi ;
Burris, Howard A. ;
de Jonge, Maja ;
Verweij, Jaap ;
Birle, Diana ;
Demanse, David ;
De Buck, Stefan S. ;
Ru, Qinhua C. ;
Peters, Malte ;
Goldbrunner, Michael ;
Baselga, Jose .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (03) :282-290
[10]   ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers [J].
Bergethon, Kristin ;
Shaw, Alice T. ;
Ou, Sai-Hong Ignatius ;
Katayama, Ryohei ;
Lovly, Christine M. ;
McDonald, Nerina T. ;
Massion, Pierre P. ;
Siwak-Tapp, Christina ;
Gonzalez, Adriana ;
Fang, Rong ;
Mark, Eugene J. ;
Batten, Julie M. ;
Chen, Haiquan ;
Wilner, Keith D. ;
Kwak, Eunice L. ;
Clark, Jeffrey W. ;
Carbone, David P. ;
Ji, Hongbin ;
Engelman, Jeffrey A. ;
Mino-Kenudson, Mari ;
Pao, William ;
Iafrate, A. John .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) :863-870